Lerntypen und Lernerfolg in der strukturierten Diabetesschulung
Projektleitung: Dr. Astrid Fink & Prof. Dr. Thomas Frese (Institut für Allgemeinmedizin)
Koordination: Karl Healy, Dr. Solveig Carmienke (Institut für Allgemeinmedizin)
Anprechpartner: Dr. Astrid Fink
Laufzeit: 01.08.2018 bis 31.07.2021
Förderer: Interne Förderung im Wilhelm-Roux-Programm im Modul Anschubantrag
Diabetes mellitus has had a wide-ranging impact on healthcare politics. Secondary diseases and complications caused by diabetes are relevant cost and utilization factors in the healthcare system. For decades, diabetes self-management education (DSME) has played a major role in the treat-ment of patients with type 2 diabetes mellitus (T2DM). The aim of this training is to empower patients to actively influence their diabetes process by gaining knowledge about health-related be-haviour, such as healthy nutrition and exercise, and cardiovascular risks. The aim of the project is to analyse the practice of structured diabetes education and the effects of different learning types of participants. This project focuses on the needs of socioeconomically deprived patients and aims to improve DSME for this group. This patient group has a higher prevalence of T2DM, more complications and worse therapy-relevant parameters.
The study will be conducted as a prospective longitudinal study. Patients will be recruited in outpatient physician offices over a period of 12 months. Patients will be included if they are 18 years and older, have T2DM and are scheduled to participate in DSME for the first time. A pseudonymized, written survey with standardized questionnaires will be administered. The data will be analysed using inferential statistical methods, such as correlation analysis, regression models and variance analytical designs.
The study will be carried out following the principles of the Helsinki Declaration and good scientific standards. Ethical approval of the Ethics Review Committee of the Medical Faculty at Martin-Luther-University (MLU), Halle-Wittenberg, was obtained. All participants in the study will receive comprehensive information and will be included after written informed consent is obtained. The results will be published in international peer-reviewed journals and presented at several con-gresses.
Registration details: This study is registered in the German Clinical Trials Register (DRKS00016630).